PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver disease |
| Phenotype | C0019196|hepatitis c |
| Sentences | 69 |
| PubMedID- 24723944 | Had underling liver disease with mostly hepatitis c virus (hcv) serologically positive (123/271, 45.4%) but not with hbv (78/271, 28.8%); however, the patients in our study were most hbv serologically positive (312/413, 75.5%). |
| PubMedID- 26444967 | Are anti-tnf-alpha agents safe for treating psoriasis in hepatitis c virus patients with advanced liver disease. |
| PubMedID- 21849046 | In one of the studies, mmp-9 levels were negatively correlated to the histological severity of the liver disease in patients with chronic hepatitis c [63]. |
| PubMedID- 25788193 | The fib-4 index was developed as a noninvasive panel for staging liver disease in patients with human immunodeficiency virus/hepatitis c virus (hcv) coinfection [14]. |
| PubMedID- 22797645 | Objective: to determine the effect of silymarin on liver disease activity in patients with chronic hepatitis c virus (hcv) infection unsuccessfully treated with interferon-based therapy. |
| PubMedID- 24224747 | We analysed data from 275 chronic hepatitis c (chc) patients with compensated liver disease who underwent 318 courses of pegifna and ribavirin. |
| PubMedID- 20386865 | The mechanisms by which alcohol consumption accelerates liver disease in patients with chronic hepatitis c virus (hcv) are not well understood. |
| PubMedID- 23226395 | liver diseases resulting from hepatitis c virus (hcv) infection is a major health issue worldwide as well as the united states [1], [2]. |
| PubMedID- 20616580 | Lipid metabolism and liver disease in hepatitis c viral infection. |
| PubMedID- 21911884 | Conclusion: based on our data, microsatellite variations in the hmox1 and ugt1a1 genes are not likely to protect from progression of liver disease in patients with chronic hepatitis c. |
| PubMedID- 21294867 | The high proportion of patients with chronic liver disease associated with hepatitis c virus coinfection might have contributed to lessen the differences between treatment groups. |
| PubMedID- 19800334 | Background & aims: human immunodeficiency virus (hiv) infection accelerates liver disease progression in patients with hepatitis c virus (hcv) and could shorten survival of those awaiting liver transplants. |
| PubMedID- 24251712 | Chronic hepatitis c is one of the liver diseases that show hepatic iron accumulation, even though its level should be recognized to be basically mild to moderate and sometimes within the normal range. |
| PubMedID- 20713178 | Prevalence and challenges of liver diseases in patients with chronic hepatitis c virus infection. |
| PubMedID- 21258658 | Hepatitis b and hepatitis c are important causes of chronic liver disease globally. |
| PubMedID- 21331379 | Tlr-mediated signals result in liver disease associated with hepatitis b, hepatitis c, alcoholicnonalcoholic steatohepatitis, and hepatic fibrosis [19]. |
| PubMedID- 19902246 | Antiviral therapy of chronic hepatitis c in patients with advanced liver disease and after liver transplantation. |
| PubMedID- 22163170 | The most common indication for lt was end-stage liver disease attributed to hepatitis c infection. |
| PubMedID- 22087124 | Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis c treated with alpha-interferon and ribavirin: rosuvastatin reduces nafld in hcv patients. |
| PubMedID- 20104219 | Conclusions: measures of cognitive function were neither influenced by low-dose peginterferon treatment nor with objective evidence of liver disease progression in patients with advanced chronic hepatitis c prospectively followed up for 3.5 years. |
| PubMedID- 21128862 | liver disease in patients with chronic hepatitis c virus (hcv) infection has an accelerated course in the presence of human immunodeficiency virus (hiv) coinfection. |
| PubMedID- 22030902 | Risk for future clinical outcomes is proportional to the severity of liver disease in patients with chronic hepatitis c virus (hcv). |
| PubMedID- 23703797 | Vitamin d is an important immune modulator that plays an emerging role in inflammatory and metabolic liver diseases, including infection with hepatitis c virus (hcv). |
| PubMedID- 24575168 | Conclusion: genetic mutations that cause inherited liver diseases in patients with hepatitis c should be studied in detail. |
| PubMedID- 24130726 | This study analyses the evolution of liver disease in women with chronic hepatitis c during the third trimester of pregnancy and the post-partum period, as a natural model of immune modulation and reconstitution. |
| PubMedID- 25030555 | Association between gene polymorphisms of connective tissue growth factor and the progression of chronic liver disease associated with hepatitis c. |
| PubMedID- 23633957 | These observations support a model of hepatic inflammation induced by phagocytic uptake of hcv by resident macrophages/kupffer cells to trigger il-1β and drive expression of proinflammatory cytokines, with il-1β expression associating with liver disease in patients with chronic hepatitis c infection (figure. |
| PubMedID- 21918437 | Management of end-stage liver disease in hiv/hepatitis c virus co-infection. |
| PubMedID- 23061403 | In high income settings, chronic liver disease – associated with hepatitis c and b virus, long term drug-induced toxicity, alcohol related and non-alcoholic fatty liver disease – has become a leading cause of chronic morbidity and mortality in people living with hiv [14]. |
| PubMedID- 20531062 | Objective: liver disease associated with hepatitis c virus (hcv) is a serious cause of mortality among people living with human immunodeficiency virus/acquired immunodeficiency syndrome (hiv/aids) (plwha). |
| PubMedID- 22359532 | Nested case control studies have a distinct advantage from traditional case control studies because both cases and controls are chosen from the same, well-defined source population, in this study from the halt-c study population where all patients had chronic hepatitis c infection with chronic liver disease. |
| PubMedID- 26417315 | hepatitis c virus infection: establishment of chronicity and liver disease progression. |
| PubMedID- 26138651 | Background: rising rates of obesity, diabetes mellitus (dm), and nonalcoholic fatty liver disease among patients with chronic hepatitis c virus infection (hcv) may contribute to more rapid disease progression. |
| PubMedID- 23945731 | It would also have been of interest had we been able to adjust for other common risk factors for hcc, such as non-alcoholic steatohepatitis, alcoholic liver disease and coinfection with hepatitis c virus (hcv), hepatitis d and hiv. |
| PubMedID- 24516785 | Abstract: hepatitis c virus infection leads to liver disease whose severity can range from mild to serious lifelong illness. |
| PubMedID- 21645344 | In this article we discuss several liver conditions which are directly affected by overweight and obese status, including non-alcoholic fatty liver disease, chronic infection with hepatitis c virus and post-liver transplant status. |
| PubMedID- 26182389 | Chronic hepatitis c is one of the liver diseases that show hepatic iron accumulation. |
| PubMedID- 26503379 | Moderate sustained virologic response rates with 6-week combination directly acting anti-hepatitis c virus therapy in patients with advanced liver disease. |
| PubMedID- 21029257 | Uptake of hepatitis c antibody testing in patients with end-stage liver disease in glasgow, 1993-2007. |
| PubMedID- 22419479 | We enrolled 184 hepatitis c-infected patients with chronic liver diseases or hcc, 57 healthy subjects and 27 hcc patients with other etiology. |
| PubMedID- 20517909 | Timing of hepatitis c antiviral therapy in patients with advanced liver disease: a decision analysis model. |
| PubMedID- 22160684 | In a significant portion of patients chronic hepatitis c infection leads to serious liver diseases, including fibrosis, cirrhosis, and hepatocellular carcinoma. |
| PubMedID- 25896946 | Decompensated liver disease resulting from hepatitis c virus (hcv) infection is a leading indication for liver transplantation [1]. |
| PubMedID- 22505377 | Background/aims: hepatitis c virus leads to chronic liver disease, cirrhosis and hepatocellular cancer. |
| PubMedID- 24695489 | End stage liver disease associated with hepatitis c virus infection constitutes one of the principal indications for liver transplant. |
| PubMedID- 20617177 | Chronic hepatitis c is associated with severe liver disease including hepatitis, liver cirrhosis and hepatocellular carcinoma and it is the most frequent indication for liver transplantation [4]. |
| PubMedID- 20334631 | Site-specific k18 hyperphosphorylation was shown to strongly correlate with the progression of liver diseases in patients with chronic noncirrhotic hepatitis c virus (hcv) [17]. |
| PubMedID- 25088088 | Background and aim: assessment of the severity of liver disease following infection with hepatitis c virus (hcv) is important in treatment selection and prognosis. |
| PubMedID- 25288416 | We found nationwide trends in increasing morbidity and medical costs for advanced liver disease associated with hepatitis c. |
| PubMedID- 22318146 | hepatitis c virus (hcv) leads to progressive liver disease and hepatocellular carcinoma. |
Page: 1 2